Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Long-Term Deferred Tax (2020 - 2021)

Historic Long-Term Deferred Tax for Neurocrine Biosciences (NBIX) over the last 3 years, with Q3 2021 value amounting to $310.4 million.

  • Neurocrine Biosciences' Long-Term Deferred Tax changed N/A to $310.4 million in Q3 2021 from the same period last year, while for Sep 2021 it was $310.4 million, marking a year-over-year change of. This contributed to the annual value of $319.4 million for FY2020, which is N/A changed from last year.
  • Per Neurocrine Biosciences' latest filing, its Long-Term Deferred Tax stood at $310.4 million for Q3 2021.
  • In the past 5 years, Neurocrine Biosciences' Long-Term Deferred Tax ranged from a high of $325.6 million in Q1 2021 and a low of $310.4 million during Q3 2021